Skip to content

A Clinical trial to study the effect of two drugs Vishayoga lepa (topical application) and Aragwadadhi kashaya (internal medication) in patients of dadru

Clinical study to evaluate the combined effect of Vishayoga lepa and Aragwadadhi kashaya in management of Dadru(Dermatophytoses)- open lable single arm study - VLAR

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040483
Enrollment
30
Registered
2022-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Shree Dharmasthala Manjunateshwara College Of Ayurveda And HospitalHassan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed subjects of dadru 2. Subjects of all gender and age group between 18-60 years will be included. 3. Disease history below 1 year

Exclusion criteria

Exclusion criteria: 1. Patients taking immune suppressive medications. 2. Pregnant women & lactating women.

Design outcomes

Primary

MeasureTime frame
accessment of patients with parameters kandu raga pidika,mandalas daha rookshata based on grades assigned to themTimepoint: followup will be after 7 days after initiation of intervention to a particular patient.

Secondary

MeasureTime frame
efficacy of drug on parameters Kandu Raga Mandalas Pidika Rookshata Daha will be notedTimepoint: parameters will be accessed after 7 days of followup

Countries

India

Contacts

Public ContactAkshatha K Shirwar

Shree Dharmasthala Manjunateshwara College Of Ayurveda And Hospital,Hassan

drashwinikumarsb@sdmcahhassan.org9449180469

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026